Target identification will commence on 17 September 2024, following the timeline provided in the campaign guidelines
Department presents a detailed overview of the Pharma and MediTechsector and gives a detailed presentation on the activities of Department
Jan Aushadhi Diwas celebrations to generate awareness about the usages of generic medicines and benefits of Jan Aushadhi Pariyojana
The department will soon release a policy to catalyze research & development and innovation in the pharma- Medtech sector in India
If the government feels that the industry is not complying with the uniform code, it will consider making it a statutory code
The three-day expo will feature an expansive exhibition showcasing MSMEs, startups, research institutions, future innovation pavilions, state showcases, and government initiatives
Government policies and competitive industry driving India’s MedTech sector for sustained double-digit growth
The company has received final approval from the Department of Pharmaceuticals, Government of India, for foreign investment under applicable regulations
The amalgamation is expected to create a future-ready, diversified CDMO platform with a technology-led focus across three high-growth verticals-Antibody Drug Conjugates
In financial year 2024-25, PMBJP has made sales of Rs. 1,760 crore (at MRP) till Feb 2025
Subscribe To Our Newsletter & Stay Updated
